| Name | Title | Contact Details |
|---|
Herakles is a Sacramento, CA-based company in the Computers and Electronics sector.
Microland is “Making digital happen” – allowing technology to do more and intrude less. Our solutions for Cloud and Datacenter, Networks, Digital Workplace, Cybersecurity, and Industrial IoT make it easier for enterprises to adopt NextGen Digital infrastructure. Microlanders throughout the world ensure this embrace of digital brilliance is predictable, reliable, and stable. Incorporated in 1989 and headquartered in Bengaluru, India, Microland has more than 4,500 digital specialists across offices and delivery centers in Asia, Australia, Europe, Middle East, and North America.
Infogain is a leading IT consulting firm with vertical solutions for the High Tech, Retail and Insurance industries and offering Knowledge Management, CRM, Integration, Mobility, Software Engineering, and Application Management solutions for enterprise clients. Its services follow the Agile methodology and span the full project lifecycle from design through development, integration, quality assurance and test, to implementation, ongoing application management and support.
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company`s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user`s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
GEMS is a Washington, DC-based company in the Computers and Electronics sector.